MARKET

MITO

MITO

Stealth BioTherapeutics
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.830
-0.140
-7.11%
After Hours: 2.110 +0.28 +15.30% 18:36 02/27 EST
OPEN
1.930
PREV CLOSE
1.970
HIGH
1.930
LOW
1.780
VOLUME
105.95K
TURNOVER
--
52 WEEK HIGH
20.99
52 WEEK LOW
1.810
MARKET CAP
60.42M
P/E (TTM)
-0.2318
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of MITO and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 6 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average MITO stock price target is 7.88 with a high estimate of 14.00 and a low estimate of 4.250.

EPS

MITO News

More
  • Stealth BioTherapeutics to Present at 40th Annual Cowen Health Care Conference
  • PR Newswire · 7h ago
  • The Daily Biotech Pulse: Gilead Kicks Off Coronavirus Drug Trials, Adcom Nod For Lily, FDA Approves Esperion's Lipid-Lowering Adjunctive Combo Therapy
  • Benzinga · 17h ago
  • The Daily Biotech Pulse: Menlo Flunks Midstage Trial, GW Pharma's Earnings, COVID-19 Updates
  • Benzinga · 1d ago
  • The Daily Biotech Pulse: Moderna Ships COVID-19 Vaccine For Clinics, Mallinckrodt Strikes $1.6B Opioid Settlement
  • Benzinga · 2d ago

Industry

Biotechnology & Medical Research
-2.24%
Pharmaceuticals & Medical Research
-2.52%

Hot Stocks

Symbol
Price
%Change
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%

About MITO

Stealth BioTherapeutics Corp. is a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction. The Company is primarily focused on developing mitochondrial targeted therapies for diseases with clear unmet medical needs including cardiovascular, renal, neurodegenerative and metabolic diseases. The Company is engaged in developing its product pipelines, which include Elamipretide, SBT-20 and SBT-272.
More

Webull offers kinds of Stealth BioTherapeutics Corp stock information, including NASDAQ:MITO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MITO stock news, and many more online research tools to help you make informed decisions.